Bariatric Times

ICCDS-1 2016

A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional

Issue link: http://bariatrictimes.epubxp.com/i/749808

Contents of this Issue

Navigation

Page 13 of 32

November 2016 • Supplement B • Bariatric Times B13 FIRST INTERNATIONAL CONSENSUS CONFERENCE ON DUODENAL SWITCH REFERENCES 1. DeMeester TR, Fuchs K, Ball C, et al. Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux. Ann Surg. Ann Surg. 1987;206(4):414–426. 2. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267–282. 3. Marceau P, Biron S, Hould FS, et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis. 2009;5(1):43–47. 4. Sánchez-Pernaute A, Herrera MA, Pérez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720-1726. 5. Bolckmans R, Himpens J. Long- term (>10 Yrs) outcome of the laparoscopic biliopancreatic diversion with duodenal switch. Ann Surg. 2016 Jan 13. [Epub ahead of print] 6. Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data. Surg Obes Relat Dis. 2016 Mar 9. pii: S1550- 7289(16)00096-4. 7. Marceau P, Biron S, Marceau S, et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes Surg. 2015;25(9):1584–1593. 8. Biertho L1, Biron S, Hould FS, et al. Is biliopancreatic diversion with duodenal switch indicated for patients with body mass index <50 kg/m2? Surg Obes Relat Dis. 2010;6(5):508–514. 9. Pata G1, Crea N, Di Betta E, et al. Biliopancreatic diversion with transient gastroplasty and duodenal switch: long-term results of a multicentric study. Surgery. 2013;153(3):413–422. Table 1.Long-term results (> 5 years) of Duodenal Switch AUTHORS FOLLOW-UP (YEARS) N WEIGHT LOSS (%) T2D REMISSION HYPERTENSION DYSLIPIDEMIA REMISSION Bolckmans et al 2016 10.8 ± 4.6 153 Total body weight loss: 40.7±10% 87.5% 81% Improved >90% Sethi et al 2016 8.9 (1-15) 100 EWL: 68% 58% 65% cured 75% Marceau et al 2015 8 (5–20) 2615 EWL: 71% (55.3 kg) 93.4% 60% Cured 91% Improved 80% Biertho et al 2010 8.6 ± 4 810 EWL: 76 ± 22 92% 60% Cured — Pata et al 2013 11.9 ± 3.1 874 BMI lost: 21 points 67% to 97% a >96% improved >96% a Remission was 67% for patients initially on Insulin and 97% when initially on oral medications.

Articles in this issue

Archives of this issue

view archives of Bariatric Times - ICCDS-1 2016